"The government had already triggered the community committees so that communities can take the ownership and contribute, and they are going house to house to identify cases and to identify contacts.Starting from the Government leadership, everything is triggered", he said.
A doctor and a nursing sister were threatened by locals after they were accused of bringing the disease to their communities, while people in one town prevented medics from testing the body of someone suspected to have died from Ebola, officials said.
Ebola virus disease, which causes fever, severe headache and in some cases hemorrhaging, most commonly affects people and nonhuman primates, such as monkeys, gorillas and chimpanzees. Health care workers have been among those infected, according to the country's health ministry. "It encourages me because I think they understand what I'm telling them".
That is one of "the very painful lessons we learned in West Africa", she said. The Ebola vaccine was 100% effective in clinical studies.
Both Guracha and Kok outlined a raft of measures taken with support from World Health Organization to prevent the entry and spread of the EVD into South Sudan.
"In previous outbreaks in DRC, community communication has proven to be crucial in terms of the effectiveness of the response to Ebola", said Yves Willemot, a UNICEF spokesman.
J&J is pushing ahead.
More than 11,300 people died in an Ebola outbreak in the West African countries of Guinea, Liberia and Sierra Leone between 2013 and 2016.
International Development Secretary Penny Mordaunt said: "The UK's robust response to the Ebola outbreak demonstrates how seriously we take such health threats around the world - and how quickly we act to contain them".
Here's what you need to know about the deadly disease.
"There are also benefits to us".
J&J's two-part vaccine - being developed with Danish biotech Bavarian Nordic - works differently to Merck's and its protection, if confirmed, is expected to be longer lasting. Health workers have drawn up a list of 628 people who have had contact with known cases who will need to be vaccinated. Nonetheless, they hope that growing awareness of the hemorrhagic fever and the risks it poses would help convince people to follow medical advice.
One problem remains the lengthy, complex and expensive process of getting new vaccines licensed by Western regulators, like the U.S. Food and Drug Administration (FDA).
The health agency called the risk to the public in Congo "very high" and the regional risk high, with the global risk low. And that is part of the plan in DRC, Berkley said. Licensure, if granted, would allow the company to market the vaccine. "It is given on a voluntary basis through informed consent and it has been approved by the DRC ethics committee as well as the regulatory committee". An FDA license is widely regarded as the definitive stamp of approval.
A major challenge will be keeping the vaccines cold in this vast, impoverished, tropical country where infrastructure is poor.
"They're not resistant", he told the Thomson Reuters Foundation by phone. Sanofi, for example, dropped development of a Zika vaccine past year, despite promising early clinical results, following a row over future pricing of the product, which was originally developed by U.S. Army researchers.
Another 8,000 are expected to arrive in coming days.
In addition to this new support, following the Ebola outbreak of 2014, United Kingdom aid worked with Wellcome to develop an experimental vaccine for the disease. "Taken together, these recent funding moves have created an air of uncertainty about the USA commitment to global health security more broadly, brought into stark relief in the midst of a new Ebola outbreak", KFF wrote.
But he stressed that not enough had been done to strengthen the "neglected health systems in distress" which permit Ebola to spread.